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Abstract
OBJECTIVE: To investigate the preventing and
treating action of Liuweidihuang pill (LP) and
Jinkuishenqi pill (JP) on spontaneous breast carci-
noma in mice.
METHODS: A model of spontaneous breast carci-
noma was derived from 11.5-month-old female
Kunming breeding mice following the delivery of
several litters. The mice were randomly divided into
five groups: model control group (C), Liuweidi-
huang pill high-dose group (LH; 4.6 g·kg﹣ 1·d﹣ 1),
Liuweidihuang pill low-dose group (LL; 2.3 g·kg﹣1·
d﹣ 1), Jinkuishenqi pill high-dose group (JH; 4.6 g·
kg ﹣ 1·d﹣ 1) and Jinkuishenqi pill low-dose group
(JL; 2.3 g·kg ﹣ 1·d ﹣ 1). Cancer tissue volume was
measured by water immersion. Histopathology was
analyzed by hematoxylin and eosin staining. Vascu-
lar endothelial growth factor (VEGF), extracellular
signal-regulated kinase (ERK) and cyclin D1 protein
expression in cancer tissue was assayed by western
blotting.
RESULTS: Compared with the control group, can-
cer tissue volume and weight were lower in the LP
and JP groups, and survival time was longer. The ex-
pression of VEGF, ERK and Cyclin D1 were inhibited
in the LP and JP groups (P < 0.05), and cell differen-
tiation was increased. Tumor weights and volumes
and VEGF, ERK and Cyclin D1 expression in LL or LH
were significantly lower than in JL and JH (P < 0.01).
CONCLUSION: Both LP and JP could restrain can-
cer growth and promote cancer cell differentiation;
moreover, LP was more effective than JP The likely
mechanism of action was via inhibition of VEGF,
ERK and cyclin D1.
© 2015 JTCM. All rights reserved.
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INTRODUCTION
Breast cancer (BC) is a common malignancy in women
and its mortality rate has increased over the past 30
years. The major treatment for breast carcinoma is still
surgery, while chemotherapy, radiation therapy, and
hormone and immune therapy serve as auxiliary ap-
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proaches. However, these therapies often give rise to
many complications, and seriously affect patient quali-
ty of life.
Clinical practices using Traditional Chinese Medicine
(TCM) have displayed significant advantages in manag-
ing breast carcinoma. Through regulating the Yin-Yang
balance of the body, it can improve the quality of life
for breast carcinoma patients by increasing survival and
improving viscera function and immunity.1,2
Breast cancer is caused by healthy Qi insufficient, long-
term deficit of liver and kidney Qi and Yin-Yang unbal-
ance. Clinical treatment often use fundoscopic (replen-
ishing Qi and blood), nourishing liver and kidney, rein-
vigoration, meantime paying attention to the Yin-Yang
balance, with emphasis on Yang; strengthening healthy
Qi and eliminating pathogenic factors, with emphasis
on strengthening healthy Qi. For strengthening healthy
Qi, more attention should be paid to the balance be-
tween Yin and Yang, regulating Qi and blood with em-
phasis on Yang, so as to striving in Yang from Yin and
striving in Yin from Yang. 3-6
Liuweidihuang pill (LP) and Jinkuishunqi pill (JP) are
provided for this type of disease.7,8 LP is not cloying,
and has the function of strengthening healthy Qi, dis-
pelling exogenous pathogens, eliminating toxicants,
and simultaneously applying purging-tonifying thera-
py.9,10 Treatment with JP, a classical Yang-reinforcing
prescription, seeks to supplement Yang with the combi-
nation of appropriate Yin so as to achieve the effect of
reinforcing Yang from Yin. The prescription is widely
used by recent generations because of its significant ef-
fects.11,12
The general principle of breast cancer prevention and
treatment is to support immune function, disperse
pathogens, nourish Yin and supplement kidney func-
tion.3,4
This study, based on TCM, explored the effect of NY
and invigorating the kidney during the treatment of
spontaneous breast carcinoma using Liuweidihuang
Wan and a classical WY prescription, Jinkuishenqi
pill. As cyclin D1, vascular endothelial growth factor
(VEGF) and extracellular signal-regulated kinase
(ERK) play very important roles in the occurrence
and development of breast carcinoma,13,14 we also ex-
plored the effect of the different treatments on these
targets.
MATERIALS ANDMETHODS
Reagents
Liuweidihuang pill (batch number 211021283) and
Jinkuishunqi big honeyed pills (batch number
Z11020054) were purchased from Beijing Tong Ren
Tang Technologies Co., Ltd., (Beijing, China). Trizol
was obtained from Invitrogen (Seattle, Washington
City in USA). VEGF, cyclin D1 and ERK monoclonal
antibodies were from Santa Cruz (Los Angeles, Califor-
nia City in USA). Horseradish peroxidase-labeled goat
anti-rabbit IgG monoclonal antibody was from Beijing
Zhongshan Golden Bridge Co., Ltd.(Beijing, China).
Methanol and phosphate buffer were domestic analyti-
cal reagents.
Animals
Three-hundred and forty female Kunming breeding
mice (aged 11.5 months, average weight 22 g) were
provided by the animal center of Jiangxi TCM (produc-
tion license No. SCSK-2011-0001). The Animal Eth-
ics Committee of National Research Institute for Fami-
ly Planning Beijing approved the animal experimenta-
tion protocols, and all animal experiments were per-
formed according to the Guidelines for the Care and
Use of Laboratory Animals established by the Chinese
Council on Animal Care. The animals were housed in
accordance with the guidelines for care and use of ani-
mals in scientific research-registered animal facilities.
The animals were maintained in cabin-type isolators at
standard environmental conditions (22-25 ℃ ,
40%-70% humidity) with a 12:12 h dark/light photo
cycle. Trained technicians palpated the mammary
glands of all animals every 3 days and noted the loca-
tion and size of all nodules using standard techniques.5,
6 At 11-18 months, 20%-30% of animals eventually de-
veloped a mammary tumor.
Following tumor development, each mouse was distrib-
uted to one of five groups using a random number ta-
ble, as follows:15,16 control group (C), Liuweidihuang
pill high-dose group (LH; 4.6 g·kg﹣1·d﹣1), Liuweidi-
huang pill low-dose group (LL; 2.3 g·kg﹣1·d﹣1), Jinkui-
shunqi pill high-dose group (JH; 4.6 g·kg﹣1·d﹣1) and
Jinkuishunqi pill low-dose group (JL, 2.3 g·kg﹣1·d﹣1).
The stock concentration of LP and J was 24 g/100 mL,
and was administered via intragastric administration.
The mice in the control group were given physiological
levels of saline to the agonal stage (symptoms: skeleton-
ization, dispirited demeanor, significantly reduced di-
etary intake, slow reactions, decreased heart rate, faint
breath or the occurrence of periodic breath) and then
killed, recording the period between the beginning of
the tumor and euthanasia. Tumors were then excised
and weighed. Final diagnosis of the breast cancer was
determined by histopathological analysis. The final vol-
ume of cancer tissue was measured by the water immer-
sion method.
The inhibitory cancer ratio was calculated as follows:
Inhibitory cancer ratio = P inhibitory = (Mmodel − Mtreat-
ment) / Mmodel × 100%
Histopathology
Mammary tumors were collected in 10% buffered for-
malin. Fixed and paraffin-embedded tissues were cut at
5-μm thickness, stained with hematoxylin and eosin
following standard procedures, and examined under a
light microscope.17
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Western blotting
Protein was extracted from fresh-frozen specimens
from 14-16 mouse mammary carcinomas and 15 nor-
mal mammary glands. Five sections of each sample
were placed in 2-mL Eppendorf safe-lock tubes and im-
mersed in Laemmli buffer for lysis. After incubation on
ice for 20 min, tissue lysates were clarified for 10 min
at 12 000 × g at 4 ℃ , denatured at 95 ℃ for 5 min,
and stored at ﹣80 ℃ until needed. For electrophore-
sis, protein extracts from fresh-frozen mammary were
subjected to Sodium dodecyl sulfate poly-acrylamide
gelelectrophoresis (SDS-PAGE) on 8% polyacrylamide
gels according to Zheng et al 18 Proteins were trans-
ferred to nitrocellulose membranes and blocked in
phosphate-buffered saline containing 0.05% Tween 20
(PBS-T), plus 5% skim milk overnight at 4 ℃ . The
membranes were then incubated with VEGF, ERK, or
cyclin D1 monoclonal mouse anti-human antibody at 1
∶1000 dilution (Santa Cruz) in PBS-T plus 2% skim
milk for 2 h, washed five times with PBS-T, and incu-
bated for 1 h with peroxidase-conjugated goat anti-rab-
bit secondary antibody (1∶1000) in PBS-T plus 2%
skim milk. After washing the membrane five times
with PBST, immunoreactivity was visualized by incuba-
tion with an enhanced chemiluminescence (ECL) and
an image was taken using an Alpha gel imager (GE
Healthcare, Fairfield, CT, USA). Measurements of gray-
scale value covering the total area of the bands were in-
tegrated. The background was subtracted.
Statistical analysis
Data analysis was carried out using SPSS 15.0 software
(SPSS Institute, Chicago, IL, USA). One-way analysis
of variance was used to compare differences. Chi-square
tests were employed to analyze categorical data. P val-
ues of < 0.05 were considered statistically significant.
RESULTS
Characteristics of tumor-bearing mice
Mammary tumors were observed only in female breed-
ing mice, mostly after delivering several litters. The age
of tumor occurrence was about 12 months (range,
10-15 months). Unmated females did not develop tu-
mors during their life span. Among 300 breeding fe-
males, 65 females developed mammary adenocarcino-
mas (incidence rate, > 20%). The tumors were unilater-
al and were observed only in 2nd or 5th or both 2nd
and 5th mammary glands. Neoplastic masses, which
reached approximately 10%-20% of the animal's body
weight at approximately 1.5 weeks, were multi-lobular
with ulceration on the skin surface. On palpation, flu-
id was observed in each lobe. Within 1-5 weeks, the tu-
mors grew rapidly, but tumor growth decelerated with
lengthening time, at which body weight began to de-
cline. At the agonal stage, mice were killed; the average
body weight was around 33 g and tumor size was ap-
proximately 18 cm3.
Cancer tissue features following Liuweidihuang pill
and Jin Kui Shun Qi pill treatment
Excised tumor masses revealed multi-lobes, and each
lobe had multiple solid nodules enclosing a central ne-
crotic core with foul-smelling inflammatory exudates
and clotted blood. The tumor masses resembled lumi-
nal/tubular epithelial-like morphology with well-differ-
entiated (Grade 1) lobes.
Tumor masses in the control group were soft and irreg-
ular-shaped, with solid nodules enclosing a central area
of necrotic tissue with foul-smelling inflammatory exu-
dates and clotted blood. The mice in the LL-dose
group had mostly gray or white, relatively hard tumor
tissue. There were few blood vessels on the surface of
the tumors with false membranes into the tumor, and
while there was less necrotic tissue than in the control
group tumors, it resembled bean curd residue. In the
LH-dose group, tumor size was relatively larger, and
the tumor tissue was softer and brown or grey, with
fewer blood vessels on the tumor surface than the con-
trol group. Coffee-like fluid was contained in tumors.
Tumor tissue in JL doses was hard, off-white, with less
vascular distribution of the surface mass, and pseudo-
capsule formation, while in JH, tumors were mainly
brown and off-white, with a brown fluid in their core.
The results revealed that treatment effectiveness in the
low-dose groups of LP and JP was better than those of
the high-dose groups.
Pathological analysis of cancer tissue after
Liuweidihuang pill and Jinkuishunqi pill treatment
The mammary gland tissue of normal mice stained
with hematoxylin eosin (HE) revealed that the cells
were of similar size, and many breast ducts were iden-
tified by microscopy. Each lobe had lobules showing
acinar or cystic patterns or a combination of acinar,
cystic and inflammatory patterns. The tubules were
lined by single or multiple layers of pleomorphic epi-
thelial cells. Some regions of the tubules were filled
with amorphous inflammatory exudates appearing as
a cystic pattern. Tumor cells were pleomorphic and
were spindle-, round-, polygonal- or signet
ring-shaped, and were small to giant-sized with nor-
mal or foamy cytoplasm and eccentric or central-
ly-placed nuclei. The neoplastic epithelial cells had in-
distinct borders, and contained scant to moderate
amounts of cytoplasm and pleomorphic nuclei with
mitotic figures. Multiple areas of necrosis with infil-
tration of neutrophils appeared between and within
lobules (Figure 1).
Under high magnification, the ducts appeared as
monolayer columnar structures. The cancer cells in the
control group were spread in flakes or nests, with a few
exhibiting a crypt-like pattern, and an increased karyo-
plasmic ratio was evident; the neoplastic epithelial cells
had pleomorphic nuclei with mitotic bodies. The pre-
liminary diagnosis was invasive ductal carcinoma (Fig-
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ure 1 A1, A2). LH cells were spread in slices, and
were of varying size with irregularly formed ducts
demonstrating secretion (Figure 1 B1, B2). In con-
trast, while LL cells were also spread in slices of dif-
ferent sizes, they formed ducts that were arranged
back-to-back, had a larger karyoplasmic ratio and the
nuclei were pleomorphic (Figure 1 C1, C2). The JH
cells were spread in slices, with a large necrotic
patch; ducts were of different sizes and shapes, and
the nuclei were large and deeply stained and exhibit-
ed obvious atypia (Figure 1 D1, D2). The JL cells
demonstrated a nested distribution with different
sized and shaped ducts and slight necrosis, and large,
deeply stained nuclei with obvious atypia (Figure 1
E1, E2). The results showed that the breast ducts of
spontaneous breast cancer mice were protected and
cell differentiation was improved after treatment with
LP and JP , moreover LL treatment group had the
best effect on pathological changes.
Cancer tissue volume, weight, and survival time
after Liuweidihuang pill and Jinkuishunqi pill
treatment
Tumor volumes of LH and JL cells were significantly
smaller compared with the control (P < 0.05 and P <
0.01, respectively), while tumor size in the JH cells was
larger than that of the LL cells, although this was not
statistically significant (P > 0.05; Figure 2A).
Tumor weights in the LL and JL were significantly low-
er compared with the control group (P < 0.01), while
those in the LH and JH were not significantly different
compared with the control group (P > 0.05). Tumor
weights in the LL and LH were higher than those of
the JL and JH, but this was not statistically significant
(P > 0.05; Figure 2B). Moreover, the cancer inhibition
ratio in the LL was obviously higher than that of the
JP (Figure 2C).
After treatment, the survival time of cancer-bearing
mice was prolonged. Among these groups, survival in
the LL was longer than that of the control (P < 0.05),
A1 B1 C1 D1 E1
A2 B2 C2 D2 E2
Figure 1 Pathological features of cancer tissue (HE staining)
Cancer cells were arranged in flakes or nests, and the proportion of nucleoplasm of cancer cells was increased in the control
group. (A1, × 100; A2, × 200). The cells were arranged in slices, and a few ducts of different sizes had formed in the LH group (B1, ×
100; B2, × 200). Ducts were arranged back-to-back. Nucleoplasms were relatively varied in size and were arge and clear-shaped in
the LL (C1, × 100; C2, × 200). In the JH (D1, × 100; D2, × 200), cell dark in color, and exhibited substantial patches of necrosis, with
large nuclei and ducts of varying size and shape. In the JL (E1, × 100; E2, × 200), nests of cells of varying shape with large nuclei
were evident, with ducts of different size and shape and little necrosis. HE: hematoxylin-eosin.
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A and D: ERK expression levels in all treatment groups (LL, LH, JL and JH) was significantly lower compared with the control (Con,
n = 12, aP < 0.01). B and E, C and F: Cyclin D1 and VEGF expression was lower in all treatment groups compared with the control
(Con, n = 13, aP < 0.01, bP < 0.05). However, the expression of all three proteins was significantly different in the LL or LH compared
with the JL or JH (P < 0.01).
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but that of the LH and JP compared with the control
was not statistically significant (P > 0. 05; Figure 2D).
These results indicated that NY treatment was better
than JP treatment.
Effect of Liuweidihuang pill and Jinkuishunqi pill
treatment on VEGF, cyclin D1 and ERK protein
expression in cancer tissue
VEGF, Cyclin D1 and ERK protein expression in can-
cer tissues was analyzed by western blotting. Compared
with the control group, VEGF, Cyclin D1 and ERK ex-
pression in the LL or LH was significantly lower (P <
0.01), and was also significantly lower in the JL (P <
0.05). Furthermore, VEGF expression in the JH and
JL was significantly lower compared with the control
(P < 0.05), but Cyclin D1 changes in the JH were not
statistically significant (P > 0. 05; Figure 3 A, B, C).
Compared with the LL or JH, VEGF, Cyclin D1 and
ERK protein expression levels in the LL and JH were
significantly lower (P < 0.01).
DISCUSSION
According to TCM, lack of healthy Qi and insufficien-
cies in Qi and blood are the main causes of breast can-
cer. Moreover, emotional injury, anxiety, and rage are
important factors in the progression of this disease.19 As
a result, breast cancer patients exhibit symptoms such
as liver-Qi stagnation, and liver and kidney Yin defi-
ciency. Therefore, the use of TCM to treat breast can-
cer through regulating Yin and Yang, supplementing
Qi and blood, and balancing viscera function has
achieved remarkable effects.3,4
In this experiment, LP and JP were used to treat spon-
taneous breast carcinoma. The results showed that they
could inhibit cancer growth, with an inhibition rate of
over 20%. Moreover, the low-dose group of both treat-
ments had a significantly greater effect compared with
the control group (P < 0.05). Both could prolong the
survival time of tumor-bearing mice, and the survival
of the LL mice was significantly longer compared with
the control group (P < 0.05). Pathological analysis
showed that both treatments could improve the patho-
logical structure of cancer tissue, and promoted the re-
covery of breast ducts and cancer differentiation, with
LL resulting in the best effect.
Both LP and JP could significantly inhibit VEGF, cy-
clin D1 and ERK protein expression compared with
the control (P < 0.01 and P < 0.05, respectively).
VEGF, Cyclin D1 and ERK protein levels in the Liu-
weidihuang pill treated groups (LL or LH) were signifi-
cantly lower compared with the JP treated groups (P <
0.01).
Yin-Yang is the general principle of syndrome differen-
tiation, and various pathological changes in malignant
tumors can be summarized as imbalances between Yin
Figure 2 Biological features of tumors after Liuweidihuang pill and Jinkuishunqi pill treatment
A: cancer tissue volume. Tumor volumes of LL and JL were significantly smaller compared with the control group (Con, n = 15, aP <
0.01). B: cancer tissue weight. Tumor weights in LL and JL were significantly smaller compared with the control group (Con, n = 16,
bP < 0.01). C: Inhibitory rate in LL and JL was higher compared with LH and JH. D: Survival time in LLwas longer compared with the
control group (Con, cP < 0.05).
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and Yang, Qi and blood. Timely correction of predomi-
nance and decline could improve the inner environ-
ment, causing our bodies to achieve dynamic balance
between Yin and Yang. LP nourishes kidney Yin, while
JP supplements kidney Yang, which enables tumor
mice to achieve a new balance between Yin and Yang
and results in inhibition of cancer growth, prolonging
the survival of tumor mice, and consequently improv-
ing the survival rate.9-12
LP prescriptions can achieve the effect of nourishing
three Yin together (kidney Yin, liver Yin and spleen
Yin) in terms of the prescription composition. For ex-
ample, Shudihuang (Radix Rehmanniae Praeparata) can
supplement kidney Yin, Shanzhuyu (Fructus Corni)
can supplement the kidney through supplementing the
liver, and Shanyao (Rhizoma Dioscoreae Oppositae) can
nourish the kidney and supplement the whole body
through nourishing the spleen. Modern pharmacology
has demonstrated that all three medicines can improve
immune function, induce the production of interfer-
ons and antioxidants, and inhibit tumor growth.20 Mu-
danpi (Cortex Moutan Radicis) regulates the immune
cells, while Poria is anti-inflammatory.21 Remedium car-
dinale consists of Fuzi (Radix Aconiti Lateralis Prepara-
ta) and Guizhi (Ramulus Cinnamomi); a small amount
in JP results in Tong Ren Tang, which means "junior
fire supporting vital Qi" and is intended to increase the
fire slightly to encourage kidney Yang, complementing
vital fire and letting the fire return to its origin. Radix
Rehmanniae supplement, for example, is included in
LP drugs to nourish Yin and produce Yin fluid, thus a
compatible prescription was based on the principle of
Yin-Yang interdependence and complementarity.22
A previous study reported that overexpression of inter-
leukin suppressed cancer cell growth in vitro, induced
cancer cell cycle arrest at the G1 phase, mediated ro-
bust apoptosis induced by serum starvation, and stimu-
lated TNF-α and IFN-γ through upregulation of Fas
and concurrent downregulation correlates with tumor
progression. Aberrant expression of VEGF is a hall-
mark of malignant tumor development required for
the colonization of endothelial cells that allow tumor
nutrition.23Thus, VEGF is a viable target for pharmaco-
logical intervention in cancer.
This provides an interesting paradigm for VEGF rela-
tionships in signal transduction in cancer. Pharmaco-
logical and genetic approaches following treatment
with Chinese medicine compound recipes were used to
dissect the signaling pathways involved in LH-/LL- or
JH-/JL -inhibition of VEGF protein expression. The
MAPK/ERK signaling pathway is generally involved in
the regulation of VEGF. MAPKs are very important
signaling components that convert extracellular stimuli
into cell proliferation. These results delineate for the
first time the mechanisms of Chinese medicine com-
pound recipe regulation of VEGF and reinforce the
idea that the disruption of VEGF signaling could im-
pact on breast cancer growth by inhibiting prolifera-
tion and angiogenesis.23
Together, the data suggest both LP and JP can inhibit
tumor growth and progression, promote the recovery
of breast ducts, stimulate the differentiation of tumor
cells, and inhibit the expression of VEGF, cyclin D1
and ERK in cancer tissues. However, the effect of LP
was obviously better than JP.
Cancer patients always exhibit symptoms of Yin defi-
ciency either before tumor development or during its
progression. LP nourishes three Yin (kidney Yin, liver
Yin and spleen Yin), while JP contains small amount
of Yang-supplementing components as well as a large
amount of Yin-nourishing components, thus, LP has
a better effect than JP in inhibiting tumor progres-
sion because excessive Yang-supplementing medicine
will result in the impairment of Yin due to the heat
it introduces.
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